A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/497 (2006.01)
Patent
CA 2614324
The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar, daunorubicin, and cytarabine. The invention is also directed to pharmaceutical formulations comprising zosuquidar, daunorubicin, and cytarabine. The formulations are particularly effective in treating newly diagnosed Acute Myelogenous Leukemia (AML).
La présente invention concerne une méthode destinée à traiter des patients présentant des tumeurs solides, des leucémies et d'autres tumeurs malignes au moyen d'une combinaison de zosuquidar, de daunorubicine et de cytarabine. L'invention concerne également des préparations pharmaceutiques comprenant du zosuquidar, de la daunorubicine et de la cytarabine. Ces préparations sont particulièrement efficaces dans le traitement d'une leucémie myélogène aiguë (LMA) nouvellement diagnostiquée.
Glenn Scott
Hoth Daniel
Marcelletti John
Multani Pratik S.
Sikic Branimir
Glenn Scott
Gowling Lafleur Henderson Llp
Hoth Daniel
Kanisa Pharmaceuticals Inc.
Marcelletti John
LandOfFree
Zosuquidar, daunorubicin, and cytarabine for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zosuquidar, daunorubicin, and cytarabine for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zosuquidar, daunorubicin, and cytarabine for the treatment... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1718208